• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变(DRD)研究的数据协调、标准化和协作:2024 年玛丽·泰勒·摩尔视觉倡议数据研讨会报告。

Data Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data.

机构信息

Wisconsin Reading Center, University of Wisconsin, Madison, WI, USA.

Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

出版信息

Transl Vis Sci Technol. 2024 Oct 1;13(10):4. doi: 10.1167/tvst.13.10.4.

DOI:10.1167/tvst.13.10.4
PMID:39361314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451832/
Abstract

The 2024 Mary Tyler Moore Vision Initiative (MTM Vision) Workshop on Data convened to discuss best practices and specific considerations for building a comprehensive, shareable MTM Vision data lake. The workshop aimed to accelerate the development of new indications, therapies, and regulatory pathways for diabetic retinal disease (DRD) by standardizing and harmonizing clinical data and ocular 'omics analyses. Standardization of data collection, the use of common data elements, and data interoperability were emphasized, alongside federated learning approaches to promote data sharing and collaboration while maintaining data privacy and security. The integration of molecular data with other multimodal data types was recognized as a promising strategy for leveraging machine learning and AI approaches to advancing therapeutics development and improving treatment outcomes for DRD patients. Partnerships with entities such as the National Eye Institute, part of the National Institutes of Health, foundations, and industry were deemed vital for the successful implementation of these initiatives.

摘要

2024 年玛丽·泰勒·摩尔视觉倡议(MTM Vision)数据研讨会召开,旨在讨论构建全面、可共享的 MTM Vision 数据湖的最佳实践和具体注意事项。该研讨会旨在通过标准化和协调临床数据和眼部“组学”分析,加速糖尿病视网膜病变(DRD)的新适应症、疗法和监管途径的发展。强调了数据收集的标准化、通用数据元素的使用和数据互操作性,以及联邦学习方法,以促进数据共享和协作,同时保持数据隐私和安全。将分子数据与其他多模态数据类型相结合被认为是利用机器学习和人工智能方法推进治疗药物开发和改善 DRD 患者治疗效果的有前途的策略。与美国国立卫生研究院的国家眼科研究所、基金会和行业等实体的合作被认为对这些计划的成功实施至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf5c/11451832/cd8c7c6a4c77/tvst-13-10-4-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf5c/11451832/cd8c7c6a4c77/tvst-13-10-4-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf5c/11451832/cd8c7c6a4c77/tvst-13-10-4-f001.jpg

相似文献

1
Data Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data.糖尿病视网膜病变(DRD)研究的数据协调、标准化和协作:2024 年玛丽·泰勒·摩尔视觉倡议数据研讨会报告。
Transl Vis Sci Technol. 2024 Oct 1;13(10):4. doi: 10.1167/tvst.13.10.4.
2
Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes.迈向一个没有糖尿病致视力丧失的世界:来自2024年玛丽·泰勒·摩尔视力倡议研讨会关于治愈糖尿病致视力丧失的见解。
Transl Vis Sci Technol. 2025 May 1;14(5):12. doi: 10.1167/tvst.14.5.12.
3
Report of the 2023 Mary Tyler Moore Vision Initiative Workshop.2023年玛丽·泰勒·摩尔视力倡议研讨会报告。
Transl Vis Sci Technol. 2025 Jul 1;14(7):11. doi: 10.1167/tvst.14.7.11.
4
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
7
Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.2022 年玛丽·泰勒·摩尔视力倡议糖尿病视网膜病变临床终点研讨会报告。
Transl Vis Sci Technol. 2023 Nov 1;12(11):33. doi: 10.1167/tvst.12.11.33.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
9
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
10
Laser photocoagulation for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的激光光凝治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD011234. doi: 10.1002/14651858.CD011234.pub2.

引用本文的文献

1
Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes.迈向一个没有糖尿病致视力丧失的世界:来自2024年玛丽·泰勒·摩尔视力倡议研讨会关于治愈糖尿病致视力丧失的见解。
Transl Vis Sci Technol. 2025 May 1;14(5):12. doi: 10.1167/tvst.14.5.12.
2
Insights from the First Five Years of the Prospective Ocular Tumor Study.前瞻性眼部肿瘤研究头五年的见解
Semin Ophthalmol. 2025 Aug;40(6):508-517. doi: 10.1080/08820538.2025.2457043. Epub 2025 Jan 28.

本文引用的文献

1
Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease.糖尿病视网膜病变分期系统更新中所考虑的基本及细胞机制原理
Ophthalmol Sci. 2024 Mar 27;4(5):100521. doi: 10.1016/j.xops.2024.100521. eCollection 2024 Sep-Oct.
2
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.糖尿病视网膜病变患者的视觉功能测量:关于现有测量方法的专家意见
Ophthalmol Sci. 2024 Apr 6;4(5):100519. doi: 10.1016/j.xops.2024.100519. eCollection 2024 Sep-Oct.
3
Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation.
蛋白质组学筛选分析儿童异基因造血干细胞移植后发现,γδ T 细胞上抑制性受体 FCRL6 的表达增加与巨细胞病毒再激活有关。
Immunol Cell Biol. 2024 Jul;102(6):513-525. doi: 10.1111/imcb.12762. Epub 2024 May 10.
4
Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment.全身因素在改善糖尿病视网膜病变预后及预测糖尿病视网膜病变治疗反应中的作用
Ophthalmol Sci. 2024 Feb 17;4(4):100494. doi: 10.1016/j.xops.2024.100494. eCollection 2024 Jul-Aug.
5
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study.接受雷珠单抗、阿柏西普和贝伐单抗治疗的致盲性眼病患者发生肾衰竭的风险相似:一项观察性健康数据科学和信息学网络研究。
Ophthalmol Retina. 2024 Aug;8(8):733-743. doi: 10.1016/j.oret.2024.03.014. Epub 2024 Mar 20.
6
Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System.评估糖尿病视网膜病变血管成分的成像方式:更新分期系统的综述与共识
Ophthalmol Sci. 2023 Dec 10;4(3):100449. doi: 10.1016/j.xops.2023.100449. eCollection 2024 May-Jun.
7
A New Approach to Staging Diabetic Eye Disease: Staging of Diabetic Retinal Neurodegeneration and Diabetic Macular Edema.糖尿病眼病分期的新方法:糖尿病视网膜神经变性和糖尿病性黄斑水肿的分期
Ophthalmol Sci. 2023 Oct 31;4(3):100420. doi: 10.1016/j.xops.2023.100420. eCollection 2024 May-Jun.
8
Advancing Toward a Common Data Model in Ophthalmology: Gap Analysis of General Eye Examination Concepts to Standard Observational Medical Outcomes Partnership (OMOP) Concepts.迈向眼科通用数据模型:普通眼科检查概念与标准观察性医学结局合作组织(OMOP)概念的差距分析
Ophthalmol Sci. 2023 Aug 25;3(4):100391. doi: 10.1016/j.xops.2023.100391. eCollection 2023 Dec.
9
Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.2022 年玛丽·泰勒·摩尔视力倡议糖尿病视网膜病变临床终点研讨会报告。
Transl Vis Sci Technol. 2023 Nov 1;12(11):33. doi: 10.1167/tvst.12.11.33.
10
Accelerating Care: A Roadmap to Interoperable Ophthalmic Imaging Standards in the United States.加速医疗:美国眼科成像互操作性标准路线图。
Ophthalmology. 2024 Jan;131(1):12-15. doi: 10.1016/j.ophtha.2023.10.001. Epub 2023 Nov 18.